Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Drop in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 2,445,800 shares, a decrease of 8.8% from the May 15th total of 2,680,500 shares. Based on an average daily volume of 4,400 shares, the short-interest ratio is currently 555.9 days.

Genomma Lab Internacional Stock Performance

Shares of GNMLF stock opened at $0.98 on Wednesday. The firm has a 50-day moving average of $0.93 and a 200-day moving average of $0.88. Genomma Lab Internacional has a one year low of $0.79 and a one year high of $0.99.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.